{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:56:49Z","timestamp":1790600209533,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijrobp.2021.01.045","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T04:58:01Z","timestamp":1612501081000},"page":"1373-1382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations"],"prefix":"10.1016","volume":"110","author":[{"given":"Susan G.R.","family":"McDuff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Bellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Gadd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.01.045_bib1","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10 801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib3","first-page":"1437","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"22","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib4","first-page":"617","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"114","author":"Van Den Bogaard","year":"1967","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib5","series-title":"AJCC cancer staging manual","year":"2017"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib6","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.2016.71.6480","article-title":"Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer","volume":"35","author":"Kurian","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: Genetic\/familial high-risk assessment: Breast and ovarian, version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1101\/sqb.2005.70.002","article-title":"The ATM-dependent DNA damage signaling pathway","volume":"70","author":"Kitagawa","year":"2005","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib9","series-title":"Mammalian cell cycle checkpoints: Signalling pathways and their organization in space and time","author":"Lukas","year":"2004"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molcel.2004.10.029","article-title":"A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to \u03b3-H2AX foci","volume":"16","author":"Riballo","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.20892\/j.issn.2095-3941.2018.0022","article-title":"ATM in breast and brain tumors: A comprehensive review","volume":"15","author":"Mehrdad","year":"2018","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib12","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1038\/sj.onc.1209873","article-title":"ATM and breast cancer susceptibility","volume":"25","author":"Ahmed","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4161\/cc.6.4.3886","article-title":"ATM and ATR: Components of an integrated circuit","volume":"6","author":"Hurley","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib14","series-title":"ATM Kinase: Methods and Protocols, Methods in Molecular Biology","first-page":"25","article-title":"ATM gene mutation detection techniques and functional analysis","author":"Rieunier","year":"2017"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djq055","article-title":"Radiation exposure, the ATM gene, and contralateral breast cancer in the women\u2019s environmental cancer and radiation epidemiology study","volume":"102","author":"Bernstein","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/jnci\/djaa031","article-title":"Radiation treatment, ATM, BRCA1\/2, and CHEK2\u22171100delC pathogenic variants, and risk of contralateral breast cancer","volume":"112","author":"Reiner","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/09553002.2017.1344363","article-title":"ATM, radiation, and the risk of second primary breast cancer","volume":"93","author":"Bernstein","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib19","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1101\/gr.135665.111","article-title":"Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24. 3 prostate cancer risk locus","volume":"8","author":"Zhang X","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ng.403","article-title":"The 8q24 cancer risk variant interaction with MYC in colorectal cancer","volume":"41","author":"Pomerantz","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11279","article-title":"The long-range interaction landscape of gene promoters","volume":"489","author":"Sanyal","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/jcp.2005.026062","article-title":"Molecular pathology of ataxia telangiectasia","volume":"58","author":"Taylor","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.embor.7400210","article-title":"ATM and ataxia telangiectasia","volume":"5","author":"McKinnon","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1259\/0007-1285-48-569-374","article-title":"Radiosensitivity in ataxia-telangiectasia","volume":"48","author":"Cunliffe","year":"1975","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: A review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpedi.1967.02090270073006","article-title":"Ataxia telangiectasia: Neoplasia, untoward response to x -irradiation, and tuberous sclerosis","volume":"114","author":"Gotoff","year":"1967","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2009.02.057","article-title":"Clinical radiation sensitivity with DNA repair disorders: An overview","volume":"74","author":"Pollard","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/1097-0142(19820901)50:5<877::AID-CNCR2820500513>3.0.CO;2-U","article-title":"The effects of radiation therapy for Hodgkin\u2019s disease in a child with ataxia telangiectasia. A clinical, biological and pathologic study","volume":"50","author":"Pritchard","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/258427a0","article-title":"Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity","volume":"258","author":"Taylor","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.20101","article-title":"Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families","volume":"42","author":"Cavaciuti","year":"2005","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/djaa095","article-title":"Pathogenic ATM mutations in cancer and a genetic basis for radiotherapeutic efficacy","volume":"113","author":"Pitter","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib32","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib33","series-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) genetic\/familial high-risk assessment: Breast and ovarian. Version 3. 2019","year":"2019"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cge.12710","article-title":"Health risks for ataxia-telangiectasia mutated heterozygotes: A systematic review, meta-analysis and evidence-based guideline","volume":"90","author":"van Os","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib35","first-page":"8717","article-title":"ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity","volume":"63","author":"Ang\u00e8le","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib36","first-page":"3325","article-title":"Contributions of ATM mutations to familial breast and ovarian cancer","volume":"63","author":"Thorstenson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.10367","article-title":"Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors","volume":"99","author":"Geoffroy-Perez","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib39","first-page":"813","article-title":"Cancer risks and mortality in heterozygous","volume":"97","author":"Thompson","year":"2005","journal-title":"ATM mutation carriers"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrc2840","article-title":"Architecture of inhereted susceptibility to common cancer","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2011.09.011","article-title":"Primer mapping rare and common causal alleles for complex human diseases","volume":"147","author":"Raychaudhuri","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib42","first-page":"1021","article-title":"Variants in the ATM gene associated with a reduced risk of contralateral breast cancer","volume":"72","author":"Concannon","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.02.040","article-title":"Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study","volume":"72","author":"Stovall","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-007-9543-6","article-title":"The spectrum of ATM missense variants and their contribution to contralateral breast cancer","volume":"107","author":"Broeks","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1668","article-title":"Identification of women with an increased risk of developing radiation-induced breast cancer","volume":"9","author":"Broeks","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijrobp.2019.07.026","article-title":"The implications of genetic testing on radiotherapy decisions: A guide for radiation oncologists","volume":"105","author":"Bergom","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/7684","article-title":"ATM haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice","volume":"21","author":"Barlow","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib48","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.162349699","article-title":"ATM heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts","volume":"99","author":"Worgul","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib49","first-page":"3725","article-title":"Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony forming ability and reduced DNA repair replication after hypoxic y-lrradiation1","volume":"39","author":"Paterson","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1440-1673.2002.01072.x","article-title":"ATM induction insufficiency in a radiosensitive breast-cancer patient","volume":"46","author":"Clarke","year":"2002","journal-title":"Aust Radiol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib51","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1038\/s41598-017-06393-8","article-title":"Evaluation of ATM heterozygous mutations underlying individual differences in radiosensitivity using genome editing in human cultured cells","volume":"7","author":"Royba","year":"2017","journal-title":"Sci Rep"},{"issue":"suppl_2","key":"10.1016\/j.ijrobp.2021.01.045_bib52","doi-asserted-by":"crossref","first-page":"ii75","DOI":"10.1093\/jrr\/rry007","article-title":"Exploration of genetic basis underlying individual differences in radiosensitivity within human populations using genome editing technology","volume":"59","author":"Miyamoto","year":"2018","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib53","first-page":"e1458","article-title":"Severe late toxicity after adjuvant breast radiotherapy in a patient with a germline ataxia telangiectasia mutated gene: Future treatment decisions","volume":"9","author":"Dosani","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib54","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1183\/13993003.01842-2015","article-title":"Monoallelic germline ATM mutation and organising pneumonia induced by radiation therapy to the breast","volume":"47","author":"Cordier","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijrobp.2021.01.045_bib55","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0360-3016(98)00295-8","article-title":"Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes","volume":"42","author":"Weissberg","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2003.08.004","article-title":"Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: No observation of increased radiation-induced acute or late effects","volume":"69","author":"Bremer","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib57","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0360-3016(99)00108-X","article-title":"Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and\/or late tissue radiation side effects","volume":"44","author":"Oppitz","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib58","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/bjc.1997.593","article-title":"Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy","volume":"76","author":"Appleby","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(11)70302-3","article-title":"Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: A prospective analysis study","volume":"13","author":"Barnett","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2010.01.016","article-title":"Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity","volume":"97","author":"Zschenker","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib61","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0360-3016(01)02684-0","article-title":"ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects","volume":"52","author":"Iannuzzi","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib62","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2007.04.012","article-title":"Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy","volume":"69","author":"Ho","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ijrobp.2021.01.045_bib63","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ijrobp.2012.02.018","article-title":"Variation in telangiectasia predisposing genes is associated with overall radiation toxicity","volume":"84","author":"Tanteles","year":"2012","journal-title":"Radiat Oncol Biol"},{"issue":"5","key":"10.1016\/j.ijrobp.2021.01.045_bib64","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2014.12.041","article-title":"Ataxia telangiectasia-mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: A systematic review and meta-analysis","volume":"91","author":"Dong","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ijrobp.2021.01.045_bib65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2016.06.017","article-title":"Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients","volume":"121","author":"Andreassen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2041-9414-1-9","article-title":"Low levels of ATM in breast cancer patients with clinical radiosensitivity","volume":"1","author":"Fang","year":"2010","journal-title":"Genome Integr"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.radonc.2004.07.010","article-title":"Breast cancer in female carriers of ATM gene alterations: Outcome of adjuvant radiotherapy","volume":"72","author":"Meyer","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib68","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/jama.286.18.2233","article-title":"Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations","volume":"286","author":"Su","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2021.01.045_bib69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162100119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162100119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:53:37Z","timestamp":1759744417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162100119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S036030162100119X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.01.045","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.01.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}